アルツハイマー型認知症：企業と競争環境...市場調査レポートについてご紹介

1 Table of Contents
1 Table of Contents 6
1.1 List of Tables 8
1.2 List of Figures 9
2 Introduction 10
2.1 Catalyst 10
2.2 Related Reports 11
3 Market Outlook 13
3.1 Global Markets 13
3.1.1 Forecast 13
3.1.2 Global Drivers and Barriers 17
4 Current and Future Players 22
4.1 Overview 22
4.2 Trends in Corporate Strategy 23
4.3 Company Profiles 25
4.3.1 GlaxoSmithKline 25
4.3.2 F. Hoffman-La Roche (Roche) 28
4.3.3 Pfizer 31
4.3.4 Novartis 34
4.3.5 AbbVie (Abbott Laboratories) 37
4.3.6 Lundbeck 39
4.3.7 Eli Lilly 42
4.3.8 Baxter International 46
4.3.9 EnVivo Pharmaceuticals 48
4.3.10 Adamas Pharmaceuticals 51
4.3.11 Johnson & Johnson 52
5 Appendix 55
5.1 Bibliography 55
5.2 Abbreviations 57
5.3 Methodology 59
5.4 Forecasting Methodology 59
5.4.1 Diagnosed AD patients 60
5.4.2 Percent Drug-treated Patients 61
5.4.3 Drugs Included in Each Therapeutic Class 61
5.4.4 General Pricing Assumptions 62
5.4.5 Generic Erosion 63
5.4.6 Alternate Scenarios 63
5.5 Physicians and Specialists Included in this Study 64
5.6 About the Authors 65
5.6.1 Author 65
5.6.2 Global Head of Healthcare 66
5.7 About GlobalData 67
5.8 Disclaimer 67